Invesaro

Stocks HYLN Financial statements

Financial statements

Hyliion Holdings Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Hyliion Holdings Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue000.22.110.671.513.48
Cost of revenue002.748.781.721.423.31
Gross profit00-2.54-6.67-1.040.090.17
Research and development9.2712.658.311082.23742.5
Selling, general and administrative9.5935.34242.624.422.8
Selling and marketing00.31.61.11.30.10.2
Operating expenses1222.293.615213664.465.7
Operating income-12-22.2-96.1-159-137-64.3-65.6
Interest expense3.265.4700
Interest income00.010.785.7213.812.28.35
Other non-operating income-2.113460-0.030.050.030
Pre-tax income3.09
Income tax0000000
Net income-14.1324-96-153-124-52-57.2
EBITDA-11-21.3-95.2-158-134-61.2-59.6
EPS, basic-0.163.11-0.56-0.87-0.68-0.30-0.33
EPS, diluted-0.16-0.35-0.56-0.87-0.68-0.30-0.33
Shares, basic (weighted)86.6104172175181175175
Shares, diluted (weighted)86.6113172175181175175

Balance sheet

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents6.2939025811912.99.2322.9
Short-term investments20211919415011169.4
Receivables0.150.090.071.140.041.920.49
Inventory0.130.110.0700
Other current assets0.4120.79.079.818.56.44.6
Total current assets6.8461238632418213198.6
Property, plant and equipment1.641.172.245.619.9925.940.5
Lease right-of-use assets4.985.067.736.477.075.433.47
Intangible assets0.430.330.240.20
Long-term investments3618010912899.660
Other non-current assets0.210.191.541.691.441.081
Total assets14.1655578447328263204
Accounts payable1.161.897.462.84.225.243.14
Accrued liabilities0.56.147.7611.510.16.624
Short-term debt6.720.05
Total current liabilities12.48.7615.214.715.114.39.86
Long-term debt9.680.910
Lease liabilities4.85.088.626.976.794.371.65
Other non-current liabilities0.180.671.520.200.04
Total liabilities32.214.924.523.222.118.711.6
Total debt9.680.910
Paid-in capital30.9365375398404408413
Retained earnings-4927517925.7-97.8-150-207
Treasury stock0-0.03-14.1-14.1
Shareholders' equity-18.1640554424306244192
Total equity-18.1640554424306244192
Total liabilities and equity14.1655578447328263204
Shares outstanding86.8169173180183174177

Cash flow statement

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-14.1324-96-153-124-52-57.2
Depreciation and amortization1.030.850.881.233.513.155.96
Stock-based compensation0.130.294.926.986.224.625.48
Deferred income tax0000000
Change in receivables-0.030.050.02-1.181.1-1.881.43
Change in payables-0.680.735.32-4.661.36-2.87-0.08
Cash from operations-11.1-22.9-80.5-117-117-56.7-46.5
Capital expenditures-0.35-0.31-2.38-2.89-7.4-16.5-23.7
Cash from investing-0.35-238-66-2218.359.560.9
Stock issued0.010.120.590.080.260.070
Share buybacks0-0.03-140
Cash from financing16.664515.9-0.08-0.02-14.3-0.67
Net change in cash5.19383-131-139-98.7-11.613.7
Free cash flow-11.4-23.3-82.9-120-124-73.3-70.3
Interest paid0.050.140.010000
Income taxes paid0000000

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.22 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin6.5%Gross profit / revenue.
Operating margin-635.2%Operating income / revenue.
EBITDA margin-551.3%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin-564.3%Net income / revenue.
FCF margin-612.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-458.2%Cash from operations / revenue.
Return on equity (ROE)-30.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-29.1%Net income / average total assets.
Return on invested capital (ROIC)-29.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue403.0%Research and development expense / revenue.
SG&A / revenue252.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue64.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue154.1%Capital expenditures / revenue.
D&A / revenue83.8%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y130.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y18.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y80.9%Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-21.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-23.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-21.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-22.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-23.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-20.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y9.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio7.59xCurrent assets / current liabilities.
Quick ratio1.68x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.40x(Cash + short-term investments) / current liabilities.
Liabilities / assets5.6%Total liabilities / total assets.
Working capital$62.2MCurrent assets - current liabilities.
Tangible book value$169.5MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.05xRevenue / average total assets.
Fixed asset turnover0.25xRevenue / average property, plant and equipment.
Inventory turnover7.44xCost of revenue / average inventory.
Days inventory49 days365 x average inventory / cost of revenue.
Receivables turnover3.46xRevenue / average receivables.
Days sales outstanding106 days365 x average receivables / revenue.
Days payables63 days365 x average accounts payable / cost of revenue.
Cash conversion cycle92 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.29Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.05Revenue / diluted weighted shares.
FCF per share-$0.32Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.24Cash from operations / diluted weighted shares.
Book value per share$0.95Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.95Tangible book value / shares outstanding.
Cash per share$0.07(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$753.7MShare price x shares outstanding.
Enterprise value$740.5MMarket cap + total debt - cash - short-term investments.
P/S81.5xMarket cap / revenue.
P/B4.45xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book4.45xMarket cap / tangible book value, when positive.
EV/Sales80.1xEnterprise value / revenue.
FCF yield-7.5%Free cash flow / market cap.
Earnings yield-6.9%Net income / market cap (the inverse of P/E).
What was Hyliion Holdings Corp.'s revenue in fiscal 2025?

Hyliion Holdings Corp. reported revenue of $3.5M for fiscal 2025, 130.3% higher than the year before.

Was Hyliion Holdings Corp. profitable in fiscal 2025?

No. It reported a net loss of $57.2M.

How much free cash flow did Hyliion Holdings Corp. generate in fiscal 2025?

Cash from operations of $46.5M minus capital expenditures of $23.7M left free cash flow of -$70.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Hyliion Holdings Corp.